0      0


Session Opening


Jun 18, 2021 6:15am ‐ Jun 18, 2021 6:20am


Credits: None available.

Description

Establishing and maintaining full transparency between industry and regulatory agencies is critical to successful daily operations, product quality, and sustainable supply. Clarifying expectations for all parties through consistentand frequent communication and through complete and accurate documentation facilitates the inspection process and when needed, guides responsesto regulatory actions. Routine follow-up holds no surprises and serves to strengthen the regulatory-industry relationship. The process of improving product quality becomes a shared goal for patient safety and access.

Session Leader(s):

  • Carmelo Rosa, PsyD, Director, Division of Drug Quality I, FDA/CDER/OC/OMQ

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content